VITZROCELL Co.,Ltd. carries a market capitalization of 1.53T, placing it among publicly traded companies globally. Its enterprise value stands at 1.46T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.53T |
| Enterprise Value | 1.46T |
VITZROCELL Co.,Ltd. trades at a trailing price-to-earnings ratio of 24.94. The price-to-sales ratio is 6.22, and the price-to-book ratio stands at 5.06.
| PE Ratio | 24.94 |
| PS Ratio | 6.22 |
| PB Ratio | 5.06 |
| P/TBV Ratio | 5.02 |
| P/FCF Ratio | 20.68 |
| P/OCF Ratio | 23.99 |
On an enterprise value basis, VITZROCELL Co.,Ltd. trades at an EV/EBITDA multiple of 19.59 and an EV/FCF ratio of 18.81. The EV/Sales ratio of 5.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.59 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.67 |
| EV / EBITDA | 19.59 |
| EV / EBIT | 19.59 |
| EV / FCF | 18.81 |
VITZROCELL Co.,Ltd. maintains a current ratio of 5.97, meaning it holds 6.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.60, indicating moderate leverage, while an interest coverage ratio of 373.28 demonstrates strong ability to service its debt obligations.
| Current Ratio | 5.97 |
| Quick Ratio | 3.28 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 0.03 |
| Interest Coverage | 373.28 |
VITZROCELL Co.,Ltd. posts a return on equity of 22.59 and a return on invested capital of 18.03.
| Return on Equity (ROE) | 22.59 |
| Return on Assets (ROA) | 17.91 |
| Return on Invested Capital (ROIC) | 18.03 |
| Return on Capital Employed (ROCE) | 22.54 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.07 |
Over the trailing twelve months, VITZROCELL Co.,Ltd. has paid 17.73B in income taxes, reflecting an effective tax rate of 21.65.
| Income Tax | 17.73B |
| Effective Tax Rate | 21.65 |
VITZROCELL Co.,Ltd.'s stock has gained approximately 146.29295% over the past 52 weeks. The 50-day moving average sits at 50,043.00, while the 200-day moving average is 29,056.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | 146.29295% |
| 50-Day Moving Average | 50,043.00 |
| 200-Day Moving Average | 29,056.73 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, VITZROCELL Co.,Ltd. generated 257.41B in revenue and converted that into 64.16B in net income, yielding earnings per share of 1,427.62. EBITDA reached 74.47B, while operating income came in at 74.47B.
| Revenue | 257.41B |
| Gross Profit | 98.75B |
| Operating Income | 74.47B |
| Pretax Income | 81.89B |
| Net Income | 64.16B |
| EBITDA | 74.47B |
| EBIT | 74.47B |
| Earnings Per Share (EPS) | 1,427.62 |
VITZROCELL Co.,Ltd. holds 143.27B in cash and equivalents against 2.04B in total debt, resulting in a net debt position of -15.45B. Total book value stands at 315.93B, with working capital of 217.15B providing operational flexibility.
| Cash & Cash Equivalents | 143.27B |
| Total Debt | 2.04B |
| Net Debt | -15.45B |
| Equity (Book Value) | 315.93B |
| Book Value Per Share | 7,029.80 |
| Working Capital | 217.15B |
VITZROCELL Co.,Ltd. produced 66.68B in operating cash flow over the past twelve months. After subtracting -10.69B in capital expenditures, free cash flow totaled 55.99B - equivalent to 1,245.95 per share.
| Operating Cash Flow | 66.68B |
| Capital Expenditures | -10.69B |
| Free Cash Flow | 55.99B |
| FCF Per Share | 1,245.95 |
VITZROCELL Co.,Ltd. operates with a gross margin of 38.36, reflecting its pricing power and cost economics. The operating margin of 28.93 and net profit margin of 24.92 provide insight into operational efficiency.
| Gross Margin | 38.36 |
| Operating Margin | 28.93 |
| Pretax Margin | 31.81 |
| Profit Margin | 24.92 |
| EBITDA Margin | 28.93 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.66 |
| FCF Yield | 4.84 |
VITZROCELL Co.,Ltd.'s most recent stock split took place on December 10, 2025 with a 1:2 split ratio.
| Last Split Date | 12/10/2025 |
| Split Ratio | 1:2 |
VITZROCELL Co.,Ltd. posts an Altman Z-Score of 22.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 22.44 |